Activation of Epstein-Barr virus in latently infected cell lines
- PMID: 2846613
- DOI: 10.1016/0166-0934(88)90068-7
Activation of Epstein-Barr virus in latently infected cell lines
Abstract
Several methods that can switch between latency and replication of Epstein-Barr virus (EBV) have been developed. These methods made it possible to identify and characterize the majority of virus proteins associated with the virus replication and to develop new assays for diagnosis. A possible activator protein encoded from the BamHI Z fragment of EBV genome, which can disrupt latency in EBV-genome positive cell lines, has also been identified. The developments in activation of the virus lytic cycle will be reviewed in this paper.
Similar articles
-
Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.Virol J. 2017 Nov 13;14(1):221. doi: 10.1186/s12985-017-0891-5. Virol J. 2017. PMID: 29132393 Free PMC article.
-
Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.J Virol. 2015 Feb;89(3):1731-43. doi: 10.1128/JVI.02781-14. Epub 2014 Nov 19. J Virol. 2015. PMID: 25410866 Free PMC article.
-
Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.J Virol. 2002 Jun;76(11):5612-26. doi: 10.1128/jvi.76.11.5612-5626.2002. J Virol. 2002. PMID: 11991990 Free PMC article.
-
Latent and lytic Epstein-Barr virus replication strategies.Rev Med Virol. 2005 Jan-Feb;15(1):3-15. doi: 10.1002/rmv.441. Rev Med Virol. 2005. PMID: 15386591 Review.
-
Lytic cycle switches of oncogenic human gammaherpesviruses.Adv Cancer Res. 2007;97:81-109. doi: 10.1016/S0065-230X(06)97004-3. Adv Cancer Res. 2007. PMID: 17419942 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources